EPO and neoplasm: Unlike hematopoietic cells, where EPO-EPOR signaling is associated with increased cell proliferation and/or survival, in tumor cells, the EPO-EPOR axis does not always lead to increased proliferation but might increase the resistance of cancer cells to different therapies.